Hepatocellular Carcinoma
Yttrium-90 TheraSphere shows promise for treatment of unresectable tumors
Published in Medical Devices and Surgical Technology Week, February 13th, 2005
In a recent study, surgeons in the United States conducted a "retrospective analysis of a new treatment modality, intra-arterial administration of Yttrium-90 TheraSphere, for unresectable hepatocellular carcinoma (HCC)."
"Patients with HCC not amenable to surgical treatment who had satisfactory physiological function without comorbid disease or significant pulmonary shunting were eligible for treatment," noted M.D. Liu and coauthors at the University of California-Irvine Medical Center. "Patients were categorized into complete, partial, or no response based...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Arthroscopic Surgery
Intra-articular approach developed for supraspinatus tendon repair - Drug Delivery
Implant tablet with week-long sustained release developed - Hip Replacement
Constrained acetabular component useful in treatment of recurrent dislocation - Virology
In situ hybridization rapidly identifies EBV infection in single cells - Acinetobacter Baumannii
Multiresistant Acinetobacter baumannii clone identified in 24 hospitals - Allergy Medicine
Sialoadhesin acts as dominant lymph node counter-receptor for mouse MGL1 - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
